Unlock stock picks and a broker-level newsfeed that powers Wall Street.
28.13
-0.06
(-0.21%)
At close: April 2 at 4:00:02 PM EDT
28.70
+0.57
+(2.03%)
Pre-Market: 6:20:42 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 4 |
| Avg. Estimate | 0 | 0 | 1.71 | 1.96 |
| Low Estimate | 0 | 0 | 0.95 | 1.06 |
| High Estimate | 0 | 0 | 2 | 2.34 |
| Year Ago EPS | -- | -- | 1.69 | 1.71 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 18 | 18 |
| Avg. Estimate | 1.41B | 1.51B | 6.06B | 6.37B |
| Low Estimate | 1.4B | 1.49B | 6B | 6.3B |
| High Estimate | 1.41B | 1.52B | 6.1B | 6.5B |
| Year Ago Sales | 1.39B | 1.44B | 5.81B | 6.06B |
| Sales Growth (year/est) | 1.18% | 4.55% | 4.38% | 5.06% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.71 | 1.96 |
| 7 Days Ago | 0 | 0 | 1.71 | 1.87 |
| 30 Days Ago | 0 | 0 | 1.63 | 1.61 |
| 60 Days Ago | 0 | 0 | 1.7 | 1.61 |
| 90 Days Ago | 0 | 0 | 1.7 | 1.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 2 | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SNN | -- | -- | 1.63% | 14.52% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Hold to Hold | 3/17/2025 |
| Downgrade | UBS: Buy to Neutral | 3/12/2025 |
| Maintains | Canaccord Genuity: Hold to Hold | 2/26/2025 |
| Upgrade | UBS: Neutral to Buy | 6/5/2024 |
| Maintains | Bernstein: Outperform to Outperform | 10/4/2023 |
| Upgrade | Redburn Partners: Sell to Neutral | 3/4/2022 |
Related Tickers
CNMD CONMED Corporation
60.43
+1.73%
OFIX Orthofix Medical Inc.
16.30
+1.81%
IART Integra LifeSciences Holdings Corporation
21.78
+0.79%
PHG Koninklijke Philips N.V.
24.84
-1.55%
STE STERIS plc
227.57
+0.82%
FNA Paragon 28, Inc.
13.08
+0.15%
ZBH Zimmer Biomet Holdings, Inc.
112.50
+0.12%
HAE Haemonetics Corporation
64.04
+1.62%
GMED Globus Medical, Inc.
75.50
+2.88%
INSP Inspire Medical Systems, Inc.
159.56
+1.00%